ArticleNeuro-oncology advances

Assessing the dose of regadenoson required to transiently alter blood-brain barrier integrity in patients with infiltrating gliomas.

Stuart A Grossman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.